YAN Chun, SUN Dafeng, ZHANG Weiya. Risk factors of surgical site infection after spinal tuberculosis surgery and establishment of a Nomogram model[J]. Journal of Clinical Medicine in Practice, 2023, 27(21): 25-31. DOI: 10.7619/jcmp.20230832
Citation: YAN Chun, SUN Dafeng, ZHANG Weiya. Risk factors of surgical site infection after spinal tuberculosis surgery and establishment of a Nomogram model[J]. Journal of Clinical Medicine in Practice, 2023, 27(21): 25-31. DOI: 10.7619/jcmp.20230832

Risk factors of surgical site infection after spinal tuberculosis surgery and establishment of a Nomogram model

More Information
  • Received Date: March 15, 2023
  • Revised Date: June 13, 2023
  • Available Online: November 23, 2023
  • Objective 

    To analyze the incidence and risk factors of surgical site infection (SSI) in patients after spinal tuberculosis surgery, and to establish a Nomogram model.

    Methods 

    Clinical materials of 280 patients diagnosed as spinal tuberculosis in Haian City People′s Hospital from January 2015 to June 2020 were retrospectively analyzed, and they were divided into training set (n=220) and validation set (n=60) according to a ratio of 4∶1. Based on the occurrence of SSI in one month after surgery, the training set was divided into SSI group (n=58) and non-SSI group (n=162), and 17 patients had SSI in the validation set. Clinical materials, blood biochemical indexes and surgical indexes were compared between SSI group and non-SSI group in the training set. LASSO and multivariate Logistic regression analysis were used to screen the best predictors, and then a Nomogram model was established.

    Results 

    Univariate analysis revealed that compared to patients in the non-SSI group, patients in the SSI group had older age, longer tuberculosis course and anti-tuberculosis treatment duration, increased number of affected segments andabscesses, higher grade of the American Spinal Injury Association (ASIA), elevated erythrocyte sedimentation rate, C-reactive protein (CRP) level and neutrophil-to-lymphocyte ratio (NLR), prolonged operation time and drainage time, increased incision length, and decreased albumin level, and all the differences were statistically significant (P < 0.05). LASSO regression screened out 6 independent predictors variables with no collinearity. Logistic regression model showed that lesion segments≥2 (OR=1.568, 95%CI, 1.321 to 1.896, P=0.001), abscess (OR=1.956, 95%CI, 1.632 to 2.358, P < 0.001), incision length ≥10 cm (OR=1.342, 95%CI, 1.124 to 1.776, P=0.003), drainage time ≥5 days (OR=1.745, 95%CI, 1.402 to 1.963, P < 0.001), NLR ≥3.5 (OR=2.023, 95%CI, 1.548 to 2.528, P < 0.001) and albumin < 35 g/L (OR=2.235, 95%CI, 1.754 to 2.569, P < 0.001) were strong predictors for occurrence of SSI. A Nomogram model was established by R software, with a total score of 220. Bootstrap method for internal validation calculated a consistency index (C-index) of 0.895 (95%CI, 0.842 to 0.943, P < 0.001), and the area under the curve (AUC) of the Nomogram model by the receiver operating characteristic (ROC) curve in predicting SSI of the training set was 0.885 (95%CI, 0.834 to 0.936, P < 0.001). External validation calculated the AUC was 0.839 (95%CI, 0.778 to 0.886, P < 0.001) for the validation set. The calibration curves for the training set and validation set demonstrated good alignment between the predicted probability of the Nomogram model and the actual incidence of SSI, and the decision curve showed that the Nomogram model for both the training set and validation set had good clinical utility.

    Conclusion 

    There is still a relatively high incidence of SSI after spinal tuberculosis surgery, and the main risk factors include the affected segment, abscess, incision length, drainage time, NLR and albumin. The Nomogram model constructed in this study has good predictive efficacy for occurrence of SSI.

  • [1]
    ANKRAH A O, GLAUDEMANS A, MAES A, et al. Tuberculosis[J]. Semin Nucl Med, 2018, 48(8): 108-130.
    [2]
    ZHANG M T, HU X C, LEI S H, et al. Trends and prospects in spinal tuberculosis research: a future-oriented approach[J]. Eur Spine J, 2023: Online ahead of print.
    [3]
    OMRAN K, ABDEL-FATTAH A S. Posterior extensive circumferential decompressive reconstructive technique in surgical treatment of upper thoracic spine compressive lesions[J]. World Neurosurg, 2019, 123: e501-e508. doi: 10.1016/j.wneu.2018.11.194
    [4]
    YANG X, LUO C, LIU L M, et al. Minimally invasive lateral lumbar intervertebral fusion versus traditional anterior approach for localized lumbar tuberculosis: a matched-pair case control study[J]. Spine J, 2020, 20(3): 426-434. doi: 10.1016/j.spinee.2019.10.014
    [5]
    LIANG X J, ZHONG W Y, TANG K, et al. One-stage posterior debridement with transverse process strut as bone graft in the surgical treatment of single-segment thoracic tuberculosis: a retrospective single-center study[J]. Medicine, 2019, 98(47): e18022. doi: 10.1097/MD.0000000000018022
    [6]
    YUAN C H, YAO Q Y, CHENG L, et al. Prognostic factors and nomogram prediction of survival probability in primary spinal cord astrocytoma patients[J]. J Neurosurg Spine, 2021, 35(5): 651-662. doi: 10.3171/2021.1.SPINE202017
    [7]
    LUAN H P, DENG Q, SHENG W B, et al. Analysis of the therapeutic effects of staged posterior-anterior combined surgery for cervicothoracic segmental tuberculosis with kyphosis in pediatric patients[J]. Int J Gen Med, 2021, 14: 4847-4855. doi: 10.2147/IJGM.S323215
    [8]
    秦世炳. 加速康复外科理念规范脊柱结核外科解决方案[J]. 中国防痨杂志, 2022, 44(6): 529-530. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFLZ202206001.htm
    [9]
    HEYDE C E, LÜBBERT C, WENDT S, et al. Spinal tuberculosis[J]. Z Orthop Unfall, 2022, 160(1): 74-83. doi: 10.1055/a-1285-4994
    [10]
    DUNN R N, BEN HUSIEN M. Spinal tuberculosis: review of current management[J]. Bone Joint J, 2018, 100-B(4): 425-431. doi: 10.1302/0301-620X.100B4.BJJ-2017-1040.R1
    [11]
    GARG RK, MALHOTRA HS, KUMAR N. Spinal Tuberculosis: Still a Great Mimic[J]. Neurol India, 2019, 67(6): 1402-1404. doi: 10.4103/0028-3886.273618
    [12]
    WANG B, WANG Y, HAO D. Current Study of Medicinal Chemistry for Treating Spinal Tuberculosis[J]. Curr Med Chem, 2021, 28(25): 5201-5212. doi: 10.2174/0929867328666201222125225
    [13]
    DONG S T, LI W L, TANG Z R, et al. Development and validation of a novel predictive model and web calculator for evaluating transfusion risk after spinal fusion for spinal tuberculosis: a retrospective cohort study[J]. BMC Musculoskelet Disord, 2021, 22(1): 825. doi: 10.1186/s12891-021-04715-6
    [14]
    KUMAR V, NERADI D, SHERRY B, et al. Tuberculosis of the spine and drug resistance: a review article[J]. Neurosurg Rev, 2022, 45(1): 217-229. doi: 10.1007/s10143-021-01595-1
    [15]
    CHAKAYA J, KHAN M, NTOUMI F, et al. Global Tuberculosis Report 2020-Reflections on the Global TB burden, treatment and prevention efforts[J]. Int J Infect Dis, 2021, 113(Suppl 1): S7-S12.
    [16]
    HASAN KHAN M N, JAMAL A B, HAFEEZ A, et al. Is spinal tuberculosis changing with changing time[J]. Ann Med Surg (Lond), 2021, 66(5): 102421.
    [17]
    AHUJA K, YADAV G, SUDHAKAR P V, et al. Role of local streptomycin in prevention of surgical site infection in TB spine[J]. Eur J Orthop Surg Traumatol, 2020, 30(4): 701-706. doi: 10.1007/s00590-019-02617-x
    [18]
    WANG B A, GAO W J, HAO D J. Current study of the detection and treatment targets of spinal tuberculosis[J]. Curr Drug Targets, 2020, 21(4): 320-327. doi: 10.2174/1389450120666191002151637
    [19]
    CHEN L Y, LIU C, YE Z, et al. Predicting surgical site infection risk after spinal tuberculosis surgery: development and validation of a nomogram[J]. Surg Infect, 2022, 23(6): 564-575. doi: 10.1089/sur.2022.042
    [20]
    KHANNA K, SABHARWAL S. Spinal tuberculosis: a comprehensive review for the modern spine surgeon[J]. Spine J, 2019, 19(11): 1858-1870. doi: 10.1016/j.spinee.2019.05.002
    [21]
    LIU H, LI Y, YI J, et al. Neutrophil-lymphocyte ratio as a potential marker for differential diagnosis between spinal tuberculosis and pyogenic spinal infection[J]. J Orthop Surg Res, 2022, 17(1): 357. doi: 10.1186/s13018-022-03250-x
    [22]
    HERSH A M, FEGHALI J, HUNG B, et al. A web-based calculator for predicting the occurrence of wound complications, wound infection, and unplanned reoperation for wound complications in patients undergoing surgery for spinal metastases[J]. World Neurosurg, 2021, 155: e218-e228. doi: 10.1016/j.wneu.2021.08.041
    [23]
    VANINO E, TADOLINI M, EVANGELISTI G, et al. Spinal tuberculosis: proposed spinal infection multidisciplinary management project (SIMP) flow chart revision[J]. Eur Rev Med Pharmacol Sci, 2020, 24(3): 1428-1434.
    [24]
    陈洋, 李卓, 焦媚, 等. 加速康复外科理念下的营养管理在围手术期脊柱结核患者中的价值[J]. 中国防痨杂志, 2022, 44(6): 549-554. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFLZ202206005.htm
    [25]
    CHEN L Y, LIU C, LIANG T, et al. Development and validation of a nomogram for predicting albumin transfusion after spinal tuberculosis surgery: based on propensity score matching analysis[J]. World Neurosurg, 2022, 157: e374-e389. doi: 10.1016/j.wneu.2021.10.102
    [26]
    谢朝云, 蒙桂鸾, 熊芸, 等. 脊柱结核患者术后手术部位感染影响因素分析[J]. 中华医院感染学杂志, 2019, 29(8): 1206-1209. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY201908017.htm
    [27]
    NAMBA T, UENO M, INOUE G, et al. Prediction tool for high risk of surgical site infection in spinal surgery[J]. Infect Control Hosp Epidemiol, 2020, 41(7): 799-804. doi: 10.1017/ice.2020.107
  • Cited by

    Periodical cited type(10)

    1. 张伟. NT-proBNP、D-D、CRP检测在中老年急性脑梗死患者中的临床诊断价值分析. 中国实用医药. 2024(10): 81-84 .
    2. 杨光,毛婷婷,陈红蕾,张海燕. 间质性肺疾病急性加重期患者外周血D-二聚体、B型钠尿肽的检测应用. 锦州医科大学学报. 2024(03): 61-65 .
    3. 刘爱平. 动态检测D-二聚体浓度在急性脑梗死患者溶栓治疗中的意义. 中国实用医药. 2023(05): 89-91 .
    4. 孙培丽,孙贵祥,许秀兰. 急性脑梗死静脉溶栓短期预后的影响因素分析. 北京医学. 2022(03): 209-212 .
    5. 张洁菁,余小萍,沈捷玉. cTnⅠ、Mb、D-D、Hcy水平变化与急性脑梗死患者预后的相关性研究. 黑龙江医药. 2021(02): 447-449 .
    6. 李海燕,肖瑾,刘兵荣,吴婷. 凝血酶原时间、活化部分凝血酶原时间、纤维蛋白原、C反应蛋白、脑钠肽检测对急性脑梗死诊断价值研究. 临床军医杂志. 2020(02): 219-221 .
    7. 刘芳卉. 急性大面积脑梗死患者的临床急救护理措施探讨. 心理月刊. 2020(07): 123 .
    8. 林梓波. 血清指标因子在急性脑梗死治疗前后的评估意义. 黑龙江医药. 2020(04): 933-934 .
    9. 俞峰,郑毅敏,张帅,吴峰. 血清可溶性肿瘤坏死因子样弱凋亡诱导因子、B型利钠肽、基质金属蛋白酶1水平与扩张型心肌病患者左心室重构的关系. 中国基层医药. 2020(12): 1472-1476 .
    10. 王珏,孙杰,徐乾治. 急性脑梗死患者的血浆D-二聚体和N末端B型钠尿肽前体水平及其意义分析. 内科. 2020(05): 592-593+610 .

    Other cited types(1)

Catalog

    Article views (98) PDF downloads (14) Cited by(11)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return